IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RA Capital Management, L.P.

Q2 2019 Holdings

Filed 2019-08-14 | 25 holdings | $614.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ascendis Pharma A S(ASND)SPONSORED ADR04351P101$475.9M4,132,44277.4%
Crinetics Pharmaceuticals Inc(CRNX)COM22663K107$46.9M1,875,2097.6%
Arvinas Inc(ARVN)COM04335A105$37.1M1,688,4126.0%
Axsome Therapeutics Inc(AXSM)COM05464T104$34.5M1,340,8285.6%
Alector Inc(ALEC)COM014442107$19.0M1,000,0003.1%
Wave Life Sciences LTD(WVE)SHSY95308105$202.9K7,775,2070.0%
Zogenix IncCOM NEW98978L204$177.9K3,722,5040.0%
RA Pharmaceuticals IncCOM74933V108$137.0K4,858,2600.0%
Synthorx IncCOM87167A103$131.4K9,724,5980.0%
Eidos Therapeutics Inc(EIDXGBP)COM28249H104$112.7K2,162,6710.0%
Orchard Therapeutics PLCADS68570P101$71.5K5,108,3300.0%
TG Therapeutics Inc(TGTX)COM88322Q108$59.5K6,880,3230.0%
Myovant Sciences LTDCOMG637AM102$59.2K6,545,6420.0%
Rhythm Pharmaceuticals Inc(RYTM)COM76243J105$41.5K1,884,7820.0%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$38.7K2,456,6690.0%
Prevail Therapeutics IncCOM74140Y101$36.2K2,743,6250.0%
Stoke Therapeutics Inc(STOK)COM86150R107$32.7K1,119,9630.0%
Kala Pharmaceuticals IncCOM483119103$28.9K4,537,4780.0%
Shockwave MED Inc(SWAVUSD)COM82489T104$28.3K495,6080.0%
Precision Biosciences IncCOM74019P108$24.4K1,842,3660.0%
Solid Biosciences IncCOM83422E105$21.3K2,689,4440.0%
G1 Therapeutics Inc(GTHXEUR)COM3621LQ109$14.8K483,9900.0%
X4 Pharmaceuticals Inc(ASNSUSD)COM98420X103$12.9K861,3930.0%
Scpharmaceuticals Inc(SCPH)COM810648105$10.4K3,247,0050.0%
Odonate Therapeutics IncCOM676079106$7.3K200,0000.0%